Docstoc

Continuous Glucose Monitoring Systems (PDF)

Document Sample
Continuous Glucose Monitoring Systems (PDF) Powered By Docstoc
					Continuous Glucose Monitoring Systems - Global Pipeline Analysis, Opportunity
Assessment and Market Forecasts to 2016

The Global Continuous Glucose Monitoring Systems Market is Forecast to Reach $216m
in 2016

The global Continuous Glucose Monitoring (CGM) systems market is expected to exhibit
a Compound Annual Growth Rate (CAGR) of 12% from 2009-2016, to reach $216m in
2016. The increasing worldwide diabetic population is the major driver for the CGM
systems market. According to the International Diabetes Federation (IDF) the global
prevalence of diabetes among adults aged 20-79 years of age is 6.6% in 2010 and will
increase to 7.8% by 2030. About 220 million people worldwide have diabetes and it will
reach 336 million by 2030. The market opportunity is high in emerging countries as 80%
of all new cases of diabetes are expected to be reported in these countries by 2025.

For Sample Pages, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/RequestSamplePages.aspx?ID=Continuous-
Glucose-Monitoring-CGM-Systems-Global-Pipeline-Analysis-Opportunity-Assessment-
and-Market-Forecasts-to-2016&Title=Medical_Devices&ReportType=Industry_Report

Also, the incidence of childhood-onset type1 diabetes in group under the age of 15 is
increasing in many countries in the world. About 76,000 children aged under 15 develop
type 1 diabetes annually, worldwide. The large and growing number of insulin dependent
diabetes patients, specifically in the US, Western Europe, and Japan, require continuous
monitoring of their glucose levels. This type 1 diabetic population serves as the major
patient pool for the usage of CGM systems. The increasing demand for non-invasive
systems is leading to the development of new technologies which in turn will increase
patient adoption of newer systems.

The US CGM systems market is expected to reach $209.5m in 2016, growing at a CAGR
of 12% from 2009 to 2016. The US remains the largest CGM market with a market share
of more than 96% in 2009. The CGM systems market in the US is going to be driven by
the increased penetration of well-established players. The high acceptance of CGM
systems from both physicians and patients coupled with a large diabetic population and
an improvement in reimbursement policies is expected to drive the US CGM systems
market in the near future.

GlobalData’s new report, “Continuous Glucose Monitoring (CGM) Systems - Global
Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016” provides key
data, information and analysis on the global Continuous Glucose Monitoring (CGM)
systems market. The report provides market landscape, competitive landscape and market
trends information on the Continuous Glucose Monitoring (CGM) systems market. The
report provides comprehensive information on the key trends affecting the market, and
key analytical content on the market dynamics. The report also reviews the competitive
landscape and technology offerings.
This report is built using data and information sourced from proprietary databases,
primary and secondary research and in-house analysis by GlobalData’s team of industry
experts.

For further details, please click or add the below link to your browser:
http://www.globaldata.com/reportstore/Report.aspx?ID=Continuous-Glucose-
Monitoring-CGM-Systems-Global-Pipeline-Analysis-Opportunity-Assessment-and-
Market-Forecasts-to-
2016&ReportType=Industry_Report&coreindustry=Industry_Report&Title=Medical_De
vices

Visit our report store: http://www.globaldata.com

For more details contact:
pressreleases@globaldata.com
North America:        +1 646 395 5477
Europe:               +44 207 753 4299
                      +44 1204 543 533
Asia Pacific:         +91 40 6616 6782

				
DOCUMENT INFO
Shared By:
Categories:
Stats:
views:83
posted:2/3/2011
language:English
pages:2
Description: The Global Continuous Glucose Monitoring Systems Market is Forecast to Reach $216m in 2016